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Abstract 
The reaction of the diazonium salt 12 derived from N-(2-aminophenyl)-N,3-dimethyl-1-phenyl-
1H-pyrazole-5-carboxamide with copper sulfate and sodium chloride in the presence of ascorbic 
acid afforded the unexpected products 3,5-dimethyl-1-phenyl-1,5-dihydro-4H-pyrazolo[4,3-c]-
quinolin-4-one (17) and N-methyl-2-(3-methyl-1-phenyl-1H-pyrazol-5-yl)aniline (19), 
accompanied by N-(2-chlorophenyl)-N,3-dimethyl-1-phenyl-1H-pyrazole-5-carboxamide (18). 
Products 17 and 19 are formed via a non-classical Pschorr reaction. The formation of 17 
represents an alternative to the literature synthesis of this biologically active compound. The 
molecular structure of 18 was confirmed by single-crystal X-ray analysis. 
 
Keywords: Pschorr, Sandmeyer reactions, 1,4-pyrazolyl transfer, fused pyrazoles, quinolines, 
1,5-hydrogen transfer 
 
 
 
Introduction 
 
Hanson and coworkers have described the use of a combination of CuSO4 and NaCl in the 
presence of ascorbic acid to perform the Sandmeyer reaction of 4-chlorobenzenediazonium 
chloride in a homogeneous aqueous phase, leading to 1,4-dichlorobenzene.1 Ascorbic acid serves 
to reduce Cu(II) to Cu(I), which, in turn, reduces the diazonium ion to a diazenyl radical. The 
latter decomposes to dinitrogen and a 4-chlorophenyl radical. Complexes of Cu(II) ions with 
chloride ions then transfer chlorine to the 4-chlorophenyl radical to afford the final product. 
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Scheme 1. i) CuSO4 / ascorbic acid / NaCl. 
 
We found earlier that, under the foregoing conditions, diazonium salt 2 affords neither the 
chloro derivative 3, the product of the classical Sandmeyer reaction, nor the tricyclic derivative 
5, the expected product of a competing Pschorr ring closure, instead a mixture of epimeric 
products 7 and 8, derived presumably via radical intermediates 4 and 6, are the major reaction 
products (Scheme 1, only a couple of epimers is represented).2 We isolated also the derivative 
11, formed via a 1,5-hydrogen atom transfer process, and trace amounts of the hydroxy spiro 
epimers 9 and 10.3 The formation of 7,8 and 9,10 may be considered as an example of 
consecutive non-classical Pschorr and Sandmeyer reactions.2 
Continuing research on this reaction,2,4,5 we became interested in investigating the behaviour 
of substrates displaying an inverted amide bridge, that is, -CONCH3- instead of -NCH3CO-, 
between the pyrazole and phenyl rings, in order to verify whether such modification influences 
the course of the reaction. In fact, -CONCH3- and -NCH3CO- groups exert opposite electronic 
effects on both the nuclei and may also influence the reactivity of radicals of the type 4 and 6. 
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Here, we describe the decomposition of the diazonium hydrogen sulfate 12 (Fig. 1), exhibiting 
an inverted amide bridge, by CuSO4/ascorbic acid in the presence of NaCl. 
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Figure 1. Diazonium hydrogen sulfates 2 and 12. 
 
 
Results and Discussion 
 
Treatment of 3-methyl-1-phenyl-1H-pyrazole-5-carboxylic acid with thionyl chloride gave the 
expected acyl chloride 13, which was condensed in situ with N-methyl-2-nitroaniline. The nitro 
group in the product 14 was reduced by hydrogenation in presence of 10% palladium on 
activated charcoal as a catalyst to give N-(2-aminophenyl)-N,3-dimethyl-1-phenyl-1H-pyrazole-
5-carboxamide (15), diazotization of which produced the diazonium hydrogen sulfate 12. 
Exposure of the latter to CuSO4 / NaCl / ascorbic acid as earlier seen with 2, afforded three 
compounds, namely: 3,5-dimethyl-1-phenyl-1,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one (17), 
N-(2-chlorophenyl)-N,3-dimethyl-1-phenyl-1H-pyrazole-5-carboxamide (18), and N-methyl-2-
(3-methyl-1-phenyl-1H-pyrazol-5-yl)aniline (19) (Scheme 2). 
The structure of 17 was ascertained by comparison (mixed melting point, TLC, MS, IR, 
NMR) with an authentic sample,6 thus ruling out the isomeric structure 16, which could have 
formed from 12 through a Pschorr reaction pathway (see Schemes 2 and 3). The structure of 18 
was confirmed by single-crystal X-ray analysis allowing a spiro structure of type 32 (Scheme 3) 
to be ruled out. 
One difference in chemical behaviour between diazonium salts 12 and 2 is attributable to the 
fragmentation of radical intermediate 29, leading to the formation of carbamoyl radical 30. No 
such reaction pathway is available to radical 6 derived from the isomeric salt 2, as fragmentation 
presumably would produce an energetic radical (see Schemes 1 and 3). Pschorr-type ring closure 
of intermediate 30 produces compound 17, while loss of carbon monoxide and hydrogen atom 
transfer to the resulting aminyl radical afford the 1,5-diphenylpyrazole derivative 19 (Schemes 3 
and 2). The transformation of 28 into 30 is an example of 1,4-pyrazolyl transfer from a carbonyl 
group to a phenyl radical. Another significant difference in chemical behaviour between 
diazonium salts 12 and 2 is the formation of the classical product of the Sandmeyer reaction 
exclusively from 12 (compound 18, Schemes 3 and 2). The above difference might be explained 
by assuming that radical 28 has a lifetime long enough to allow its reaction with the chloro-
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copper(II) complexes to give 18, whereas radical 4 converts readily into the stable radical 6 
which, in turn, affords the epimers 7,8 and 9,10, as well as to compound 11 by a 1,5-hydrogen 
atom transfer process3 (Scheme 1). 
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Scheme 2. i) CuSO4/ascorbic acid/NaCl. 
 
Lastly, we note that pyrazolo[4,3-c]quinoline 17 and congeners are of interest as agonists of 
the central benzodiazepine receptor. For instance, compound 17 itself displaces 
[3H]flunitrazepam from its receptor site in bovine brain membranes with a IC50 value of 3.4±0.2 
µM.6 The preparation of 17 by reaction of the diazonium salt 12 with the CuSO4/ascorbic acid 
system represents a valuable alternative to the synthetic method reported in literature. 
Furthermore, compound 17 has a planar structure, and as a consequence, it may be able to 
intercalate into the DNA double helix and express antiproliferative activity. Indeed, testing of 17 
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against the HL-60 (Human promyelocytic leukemia) cell line, revealed a 40% cell growth 
inhibition at a 10 µM concentration. 
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Scheme 3. Suggested mechanism for the transformation of 12. 
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Crystal structure of compound 18 
The crystal structure of 18 is shown in Figure 2 as ORTEP7 view.  
 
 
 
Figure 2. ORTEP7 drawing of 18 with the atom numbering scheme (ellipsoids are at 50% 
probability). 
 
The overall conformation of the molecule is defined by the torsion angles C5-C4-N2-N1 of 
66.4(3)° and C10-N3-C11-C16 of 69.2(3)° that indicate a significant tilting of the phenyl 
moieties with respect to the rest of the molecule. This is best evidenced by the dihedral angles of 
66.1(1)° and 75.1(1)° between the pyrazole with the phenyl and o-chlorophenyl rings, 
respectively, while the dihedral angle between the two benzene is 38.7(1)°. The geometrical 
parameters show the presence of an electronic delocalization in the whole molecule. In 
particular, the short distance found between C3 and C11 suggests the presence of a resonance 
effect across the C-C bond linked to the amide fragment. In addition, the N-Cphenyl bond distances 
are shorter than those of the N-Cmethyl, indicating that the orientation of the phenyl rings slightly 
influences the conjugative effect on the respective adjacent bond of the moiety to which they are 
linked. This is in agreement with our previously published results.4 
In the crystals, the molecules are connected by weak intermolecular Cpi-H…O type 
interactions, as shown in Figure 3. These contacts involve C12-H12...O1I  (I at 1/2-x, y+1/2, 3/2-
z) at a distance of 2.57(1) Å, angle 166(1)°, and C6-H6...O1II  (II at -x,-y+1,-z+1), at a distance of 
2.62(1) Å, angle 162(1)°, giving rise to a two-dimensional molecular arrangement. 
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Figure 3. Intermolecular interactions (in dashed lines) of 18 viewed along the b axis. For the 
sake of clarity, only the hydrogen atoms involved in Cpi-H…O contacts are represented. 
 
 
Conclusions 
 
The product distribution observed in the reaction of the copper sulfate/ascorbic acid/sodium 
chloride system with the isomeric diazonium salts 2 and 12, wherein the amide bridge that links 
the pyrazole and benzene rings is inverted, differs significantly as a consequence of different 
lifetimes of radicals 28 and 4 as well as of the distinct chemical reactivity of radical 
intermediates 29 and 6. 
 
 
Experimental Section 
 
Chemistry  
General. Reaction progress was monitored by TLC on silica gel plates (Merck 60, F254, 0.2 mm). 
Organic solutions were dried over Na2SO4. Evaporation refers to the removal of solvent on a 
rotary evaporator under reduced pressure. All melting points were determined on a Büchi 530 
capillary melting point apparatus and are uncorrected. IR spectra were recorded with a Perkin 
Elmer Spectrum RXI FT-IR System spectrophotometer as solids in KBr discs. 1H-NMR and 13C-
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NMR spectra were obtained in CDCl3 at 300.13 and 75.47 MHz respectively, using a Bruker AC 
series 300 MHz spectrometer (tetramethylsilane as an internal standard): chemical shifts are 
expressed in δ values (ppm). Mass spectra at 70 eV were obtained using an Autospec Ultima 
Orthogonal T.O.F.T. (Micromass) spectrometer. Merck silica gel (Kiesegel 60/230-400 mesh) 
was used for flash chromatography columns. Microanalysis data (C, H, N) were obtained by an 
Elemental Vario EL. III apparatus. Yields refer to products obtained after one crystallization. 
 
3-Methyl-1-phenyl-1H-pyrazole-5-carbonyl chloride (13). 3-Methyl-1-phenyl-1H-pyrazole-5-
carboxylic acid8 (2.22 g, 11 mmol) was reacted with SOCl2 (8 ml) under reflux for 5 h. The 
solution was evaporated under reduced pressure and the brown oily residue obtained was used in 
the next step. 
N,3-Dimethyl-N-(2-nitrophenyl)-1-phenyl-1H-pyrazole-5-carboxamide (14). A solution 
containing 13 obtained as above and N-methyl-2-nitroaniline (3.34 g, 22 mmol) in dry 
acetonitrile (50 ml) was refluxed for 10 h. The solution was evaporated under reduced pressure, 
and the residue was washed with ethyl ether (2x10 ml) and then crystallized  from  ethyl acetate/ 
light petroleum ether (b.p. 40-70 °C) to give 14, as a pale yellow solid, in 70% yield (referred to 
to 3-Methyl-1-phenyl-1H-pyrazole-5-carboxylic acid), 2.6 g, mp: 150-52 °C. MS (m/z): 336 
(M+). IR (νmax, cm-1): 1660 (CO). 1H-NMR: δH 2.16 (3H, s, Me), 3.36 (3H, s, Me), 6.00 (1H,s, 
pyrazole H-C(4) ), 7.26 – 8.03 (9H, m, C6H5 and C6H4); Anal. Calcd. for C18H16N4O3 (336.34) : 
C, 64.28; H, 4.79; N, 16.66. Found: C, 64.28; H, 4.99; N, 16.90%. 
(2-Aminophenyl)-N,3-dimethyl-1-phenyl-1H-pyrazole-5-carboxamide (15). A solution of 14 
(2.49 g, 7.4 mmol) in ethanol (250 ml) was mixed with 0.5 g of 10% palladium on activated 
charcoal as a catalyst and shaken in a Parr apparatus under 45-50 psi of hydrogen for 24 h. 
Filtration to separate the catalyst and evaporation under vacuum of the solvent yielded a residue 
which was crystallized from ethyl acetate to give (2-aminophenyl)-N,3-dimethyl-1-phenyl-1H-
pyrazole-5-carboxamide 15, as a colourless solid, in 74% yield, 1.7 g, mp: 113-114 °C. MS 
(m/z): 306 (M+). I.R.( νmax, cm-1): 3436 and 3334 (NH2), 1646 (CO). 1H-NMR: δH 2.18 (3H, s, 
Me), 3.22(3H, s, Me), 3.33 (2H, s, exchangeable with D2O, NH2), 6.12 (1H, s, pyrazole H-C(4)), 
6.51-7.44 (9H, m,  C6H5 and C6H4). 13C-NMR : δC 13.35 (CH3), 35.37 (CH3), 108.72 (CH), 
116.29 (CH), 118.78 (CH), 124.10 (CH), 127.65 (CH), 128.35 (C), 128.41 (CH), 129.00 (CH), 
129.26 (CH), 137.09 (C), 140.41 (C), 142.50 (C), 148.80 (C), 163.34 (CO); Anal. Calcd. for 
C18H18N4O (306.36) : C, 70.57; H, 5.92; N, 18.29. Found: C, 70.82; H, 6.20; N, 18.59%.  
2-(N,3-Dimethyl-1-phenyl-1H-pyrazole-5-carboxamido)benzenediazonium hydrogen sulfate 
(12). The pulverized amine 15 (0.998 g, 3.26 mmol) was dissolved in cooled (0-5 °C) 2.5 mol 
dm-3 aqueous sulfuric acid (6.5 ml), and 2.5 mol dm-3 aqueous sodium nitrite (1.34 ml) was added 
drop wise to the stirred solution. The solution was stirred for a further 15 min in the ice bath and 
then checked with potassium iodide starch paper for excess of nitrous acid; the eventual excess 
can be destroyed by addition of urea. 
Decomposition of the diazonium hydrogen sulphate 12. To a cold (0 – 5 C) soln. (170 ml) of 
CuSO4.5H2O (0.3 M) and NaCl (0.75 M), first the soln. of 12 obtained from the previous 
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procedure, and then ascorbic acid (140 mg, 0.795 mmol) were added under stirring. The mixture 
was stirred for 1 h at r.t. and then filtered. The solid product obtained was dried in a desiccator 
(anhydrous CaCl2) for 24 h and then processed by flash chromatography9 (external diameter of 
the column 5.5 cm, silica gel (0.040 - 0.063 mm, 170 g), ethyl ether/light petroleum ether (b.p. 
40-70 °C) 1:1 as eluent; fractions 50 ml each. The initial eleven fractions were discarded and 
fractions 12-19 were evaporated under reduced pressure to give 125 mg of a mixture that was 
crystallized from petroleum ether (b.p. 100-140 °C) to give N-methyl-2-(3-methyl-1-phenyl-1H-
pyrazol-5-yl)aniline (19) as a colourless solid, in 10% yield, 85.8 mg, mp: 109–110 °C. MS 
(m/z): 263 (M+). IR (νmax, cm-1): 3411 (NH). 1H-NMR: δH 2.41 (3H, s, Me), 2.75 (3H, s, Me), 
4.00 (1H, s, exchangeable with D2O, NH), 6.29 (1H, s, pyrazole H-C(4) ), 6.57-7.29 (9H, m, 
C6H5 and C6H4); Anal. Calcd. for C17H17N3 (263.34) : C, 77.54; H, 6.51; N, 15.96. Found: C, 
77.30; H, 6.40; N, 15.80%.  
Frs 22-31 were evaporated under vacuum and the residue (110 mg) was crystallized from 
petroleum ether (b.p. 100-140 °C) to give N-(2-chlorophenyl)-N,3-dimethyl-1-phenyl-1H-
pyrazole-5-carboxamide (18) as a colourless solid, in 7.55 % yield, 80 mg, mp: 114-17 °C. MS 
(m/z): 325 (M+). IR (νmax, cm-1): 1655 (CO). 1H-NMR: δH 2.15 (3H, s, Me), 3.28 (3H, s, Me), 
5.98 (1H, s, pyrazole H-C(4)), 6.69-7.46 (9H, m, C6H5 and C6H4). 13C-NMR: δC 13.30 (CH3), 
36.51 (CH3), 108.84(CH), 123.94 (2xCH), 127.60 (CH), 127.71 (CH), 128.93 (2xCH), 128.48 
(CH), 129.54 (CH), 130.44 (CH), 132.53 (C), 136.80 (C), 140.21 (C), 140.27 (C), 148.60 (C), 
162.23 (CO); Anal. Calcd. for C18H16ClN3O (325.79) : C, 66.36; H, 4.95; N, 12.90. Found: C, 
66.56; H, 4.70; N, 12.65 %.  
Frs 49-61 were evaporated under vacuum, and the residue (370 mg) was crystallized from 
ethanol (95% v/v) to give a colourless solid in 20% yield, 189 mg, identicall in all respect (mixed 
melting point, TLC, MS, 1H NMR, 13C NMR, IR) to a authentic specimen of 3,5-dimethyl-1-
phenyl-1,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one6 (17), mp 187-88 °C. MS (m/z): 289 (M+). 
IR (νmax, cm-1): 1657 (CO). 1H-NMR: δH 2.76 (3H, s, Me), 3.75 (3H, s, Me), 6.94-7.60 (9H, m, 
C6H5 and C6H4). 13C-NMR: δCL  13.27 (CH3), 29.00 (CH3), 111.32 (C), 112.18 (C), 115.60 (CH), 
121.56 (CH), 123.13 (CH), 127.16 (2xCH), 129.66 (CH), 129.77 (2xCH), 129.89 (CH), 
136.8139.720 (C), 140.36 (C), 140.45 (C), 149.38 (C), 159.62 (CO). 
 
Crystallography  
Crystals of 18 suitable for X-ray crystallography were grown by slow evaporation of petroleum 
ether solutions (b.p. 100-140 °C). They were mounted on an Enraf Nonius CAD-4 diffractometer 
using Mo-Kα (λ= 0.71073 Å) radiation at 293(2)K. The lattice parameters were determined by 
least-squares refinements of 25 high angle reflections. The structure was solved by direct 
methods10 and the refinements were carried out by full-matrix least-squares with SHELX-97 
package11 and WINGX12. All non-H-atoms were refined anisotropically. Hydrogen atoms were 
detected in a difference Fourier synthesis and refined with isotropic thermal factors. Geometrical 
calculations were carried out using the program PARST.13  
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The crystallographic data were deposited with the Cambridge Crystallographic Data Centre 
(CCDC deposition number 822400). Copies can be obtained gratis from CCDC, 12 Union Road, 
Cambridge CB2 1EZ, UK; fax: +44(1223) 336033; e-mail: deposit@ccdc.cam.ac.uk). 
Crystal data for 18. C18H16ClN3O, Mr = 325.80 g mol−1, Monoclinic, Space group P21/n,  a = 
13.958(1)  Å, b = 7.210(6) Å, c = 16.433(4) Å, β= 97.81(1)°, V = 1638(1) Å3, Z = 4, Dc = 1.321 
Mg m−3, R = 0.039 (3754 reflections), wR2 = 0.089, T = 293(2) K, GOF = 1.023. The reflections 
were collected in the range 2.06°≤θ≤24.98° employing a 0.9 × 0.8 × 0.7 mm crystal. 
 
Biology 
Antiproliferative activity in vitro. Compound 17 was tested in vitro for antileukemic activity 
against HL-60 (Human promyelocytic leukemia) cell line. The cells were grown at 37 °C in a 
humidified atmosphere containing 5% CO2, in RPMI-1640 medium (Biochrom KG) 
supplemented with 10% fetal calf serum and antibiotics. Cells were suspended at a density of 
2X105 cells per ml in growth medium, transferred to 24-well plate (1 ml per well), cultured with 
or without (control wells) screening concentration of compound and incubated at 37 °C for 48 h. 
Control wells were added with DMSO used to dissolve the compound to exclude a solvent 
activity. Numbers of viable cells were determined by counting in a hematocytometer after dye 
exclusion with trypan blue14. We determined at a concentration of 10 µM the % of growth 
inhibition than the untreated growth control. 
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